Delivery Order SPE2DB24D2100-SPE2DB24FBATV
Award Date
4/5/24
Potential Completion Date
4/8/24
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order worth $9,535.20 to AmerisourceBergen Drug Corporation's Corporate Office Division. The order is for the supply of GARDASIL 9, a 0.5 ml syringe vaccine, with a period of performance through September 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide GARDASIL 9 vaccine syringes. The $19,401.36 contract has an ultimate completion date of April 11, 2024. AmerisourceBergen Drug Corp, a for-profit organization, is the prime contractor on this award. This delivery order falls under a larger $999,999,999.00 indefinite delivery contract between...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide GARDASIL 9 syringes. The $16,985.52 contract has a completion date of February 22, 2024. AmerisourceBergen Drug Corp is the prime contractor and there are no set-aside designations associated with this award. This delivery order is issued under an indefinite delivery contract (IDC) between DLA and...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide GARDASIL 9 SYRINGE 0.5ML pharmaceutical products. The contract, valued at $20,560.75, has a completion date of January 31, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and is not operating under any set-aside designation....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $6,528.44 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of GARDASIL 9 vaccine syringes. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded to AmerisourceBergen Drug Corp as the sole prime contractor, which serves as the primary vehicle for the company to provide a range of pharmaceutical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $1,616.78 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of GARDASIL 9 syringes. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide GARDASIL 9 SYRINGE 10S, a pharmaceutical product. The $28,867.54 contract has an ultimate completion date of April 5, 2024. AmerisourceBergen Drug Corp is the prime contractor and the parent company is Cencora, Inc. which does business as AmerisourceBergen. This...
The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of GARDASIL 9 SYRINGE 0.5ML. The delivery order has a completion date of February 23, 2024 and a potential value of $7,335.52. Amerisourcebergen Drug Corp serves as the prime contractor for this award, which is not a set-aside contract. The company also holds a $999,999,999.00 indefinite delivery...
The U.S. Defense Logistics Agency (DLA) awarded a $9,366.31 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of GARDASIL 9 syringes. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract valued at $9,761.55 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,684,229 units of GARDASIL 9 vaccine syringes (0.5 mL) with a completion date of September 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025,...